{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:10:17Z","timestamp":1792285817620,"version":"4.4.0"},"reference-count":27,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,5]]},"abstract":"<jats:p>\n                    Treatment options for cutaneous leishmaniasis in the United States are problematic because the available products are either investigational, toxic, and\/or of questionable effectiveness. A retrospective review of patients receiving liposomal amphotericin B through the Walter Reed Army Medical Center for the treatment of cutaneous leishmaniasis during 2007\u20132009 was conducted. Twenty patients who acquired disease in five countries and with five different strains of\n                    <jats:italic>Leishmania<\/jats:italic>\n                    were treated, of whom 19 received a full course of treatment. Sixteen (84%) of 19 experienced a cure with the initial treatment regimen. Three patients did not fully heal after an initial treatment course, but were cured with additional dosing. Acute infusion-related reactions occurred in 25% and mild renal toxicity occurred in 45% of patients. Although the optimum dosing regimen is undefined and the cost and toxicity may limit widespread use, liposomal amphotericin B is a viable treatment alternative for cutaneous leishmaniasis.\n                  <\/jats:p>","DOI":"10.4269\/ajtmh.2010.10-0171","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T07:28:05Z","timestamp":1288337285000},"page":"1028-1033","source":"Crossref","is-referenced-by-count":146,"title":["Lipsosomal Amphotericin B for Treatment of Cutaneous Leishmaniasis"],"prefix":"10.4269","volume":"83","author":[{"given":"Glenn","family":"Wortmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zapor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseanne","family":"Ressner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Hartzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Weintrob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Magill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"R1","series-title":"Principles and Practices of Infectious Diseases","first-page":"3463","volume":"Volume 2","author":"Magill","year":"2010"},{"key":"R2","series-title":"Clin Infect Dis","first-page":"1457","article-title":"Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience","volume":"27","author":"Aronson","year":"1998"},{"key":"R3","series-title":"Clin Infect Dis","first-page":"261","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20- day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann","year":"2002"},{"key":"R4","series-title":"Clin Infect Dis","first-page":"509","article-title":"Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis","volume":"27","author":"Wortmann","year":"1998"},{"key":"R5","series-title":"Trans R Soc Trop Med Hyg","first-page":"264","article-title":"Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travelers","volume":"100","author":"Lawn","year":"2006"},{"key":"R6","author":"Drug Alert","year":"2006"},{"key":"R7","series-title":"Clin Infect Dis","first-page":"42","article-title":"U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis","volume":"28","author":"Meyerhoff","year":"1999"},{"key":"R8","series-title":"Acta Trop","first-page":"127","article-title":"Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients","volume":"92","author":"Amato","year":"2004"},{"key":"R9","series-title":"Br J Dermatol","first-page":"203","article-title":"Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis","volume":"153","author":"Brown","year":"2005"},{"key":"R10","series-title":"J Eur Acad Dermatol Venereol","first-page":"11","article-title":"Recidivans cutaneous leishmaniasis unresponsive to liposomal amphotericin B (AmBisome)","volume":"14","author":"G\u00fcnd\u00fcz","year":"2000"},{"key":"R11","series-title":"J Cutan Pathol","first-page":"701","article-title":"Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient","volume":"33","author":"Mirzabeigi","year":"2006"},{"key":"R12","series-title":"J Infect","first-page":"e261","article-title":"Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B","volume":"51","author":"Paradisi","year":"2005"},{"key":"R13","series-title":"Bull Soc Pathol Exot","first-page":"209","article-title":"Liposomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate","volume":"96","author":"Rapp","year":"2003"},{"key":"R14","series-title":"Eur J Dermatol","first-page":"281","article-title":"Leishmaniasis due to L. infantum presenting as macrocheilitis and responding to liposomal amphotericin B","volume":"19","author":"Rongioletti","year":"2009"},{"key":"R15","series-title":"J Trop Pediatr","first-page":"122","article-title":"Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases","volume":"56","author":"Del Rosal","year":"2010"},{"key":"R16","series-title":"J Am Acad Dermatol","first-page":"612","article-title":"Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis","volume":"56","author":"Solomon","year":"2007"},{"key":"R17","series-title":"Clin Infect Dis","first-page":"1024","article-title":"Successful treatment of antimony-resistant cutaneous leishmaniasis with liposomal amphotericin B","volume":"18","author":"Torre-Cisneros","year":"1994"},{"key":"R18","series-title":"J Travel Med","first-page":"395","article-title":"Imported leishmaniasis: a heterogeneous group of diseases","volume":"16","author":"P\u00e9rez-Ayala","year":"2009"},{"key":"R19","series-title":"Am J Trop Med Hyg","first-page":"583","article-title":"Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction","volume":"65","author":"Wortmann","year":"2001"},{"key":"R20","series-title":"Am J Trop Med Hyg","first-page":"199","article-title":"Characterization of Leishmania spp. by isozyme electrophoresis","volume":"29","author":"Kreutzer","year":"1980"},{"key":"R21","series-title":"Am J Trop Med Hyg","first-page":"22","article-title":"Biochemical identities and differences among Leishmania species and subspecies","volume":"36","author":"Kreutzer","year":"1987"},{"key":"R22","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","author":"National Cancer Institute","year":"2006"},{"key":"R23","series-title":"Clin Infect Dis","first-page":"1213","article-title":"Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics","volume":"36","author":"Roden","year":"2003"},{"key":"R24","series-title":"Clin Infect Dis","first-page":"223","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmanisis in Peru","volume":"46","author":"Llanos-Cuentas","year":"2008"},{"key":"R25","series-title":"Parasitol Res","first-page":"1319","article-title":"Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs","volume":"101","author":"Hadighi","year":"2007"},{"key":"R26","series-title":"Int J Antimicrob Agents","first-page":"243","article-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley","year":"2000"},{"key":"R27","series-title":"Clin Infect Dis","first-page":"1006","article-title":"Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis","volume":"26","author":"Wortmann","year":"1998"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/83\/5\/article-p1028.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/83\/5\/article-p1028.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/83\/5\/article-p1028.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T12:25:25Z","timestamp":1725279925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/83\/5\/article-p1028.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,5]]},"references-count":27,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.2010.10-0171","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,5]]}}}